Related Experiment Video

Updated: Aug 7, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

Alternative splicing variants of IRF-1 lacking exons 7, 8, and 9 in cervical cancer

Eun-Ju Lee1, Minwha Jo, Junsoo Park

  • 1Molecular Therapy Research Center, Sungkyunkwan University, Seoul 135-710, Republic of Korea.

Biochemical and Biophysical Research Communications
|July 22, 2006
PubMed

Insights

New interferon regulatory factor 1 (IRF-1) splice variants were found in cervical cancer. These variants negatively regulate IRF-1 activity, suggesting a role in cervical cancer development.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Interferon regulatory factor 1 (IRF-1) is a key transcription factor.
  • Previously identified IRF-1 splice variants did not significantly impact gene activation.

Purpose of the Study:

  • To identify novel splice variants of IRF-1.
  • To investigate the functional consequences of these variants on IRF-1 activity.
  • To explore the role of IRF-1 alternative splicing in cervical cancer.

Main Methods:

  • Reverse transcription polymerase chain reaction (RT-PCR) was used.
  • Analysis was performed on normal and malignant human cervical tissue samples.
  • Predicted protein structures and transcriptional activities of variants were assessed.

Main Results:

  • Five novel IRF-1 splice variants, lacking combinations of exons 7, 8, and 9, were identified.
  • These variants were expressed at higher levels in malignant cervical tissues.
  • Variants exhibited altered transcriptional activities, attenuating wild-type IRF-1 function.
  • Variant mRNA levels were consistent across the cell cycle, unlike wild-type IRF-1.
  • Variant proteins showed increased stability compared to wild-type IRF-1.

Conclusions:

  • Alternative splicing of IRF-1 exons 7, 8, and 9 is a significant mechanism for negative regulation.
  • These splice variants may play a crucial role in the pathogenesis of cervical cancer.
  • The increased stability and inhibitory function of variants contribute to IRF-1 downregulation in cervical cancer.

More Related Videos

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

Related Concept Videos

Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...